PRFX PainReform Ltd.

We are a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics.

$0.54  -0.02 (-3.26%)
As of 03/22/2023 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Israel
Country of incorporation:  
IPO date:  09/01/2020
Outstanding shares:  10,634,166
Average volume:  23,378
Market cap:   $6,210,353
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%